Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi…
| Source | FDA · Drugs (US) |
|---|---|
| Date | 2026-09-02 |
| Product | Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20. |
| Reason / hazard | Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles. |
| Classification | Class I |
| Official notice | — |
| Record ID | fda-drug:D-0827-2026 |